Literature DB >> 9056551

Agenesis of the corpus callosum in a mother and son.

D Inbar1, G J Halpern, R Weitz, M Sadeh, M Shohat.   

Abstract

Most reported familial cases of agenesis of the corpus callosum have followed either an autosomal recessive or an X-linked recessive pattern of inheritance. To the best of our knowledge, there is only one previous report of a family showing clear-cut autosomal dominant inheritance. We present the second such family, among whom a mother and her son had moderately severe coordination problems and low-normal intelligence. We suggest that agenesis of the corpus callosum, when transmitted as an autosomal dominant trait, is clinically characterized by a relatively milder phenotype than that occurring when inheritance is either autosomal or X-linked recessive and may be more common than has been thought.

Entities:  

Mesh:

Year:  1997        PMID: 9056551

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Agenesis of the corpus callosum with Probst bundles owing to haploinsufficiency for a gene in an 8 cM region of 6q25.

Authors:  B Pirola; L Bortotto; S Giglio; E Piovan; A Janes; R Guerrini; O Zuffardi
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

2.  Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.

Authors:  Michelle S Jang; Ashley N Roldan; Ricardo F Frausto; Anthony J Aldave
Journal:  Vision Res       Date:  2014-04-26       Impact factor: 1.886

3.  Dominantly inherited cerebral dysplasia: arachnoid cyst associated with mild mental handicap in a mother and her son.

Authors:  J L Tolmie; R Day; B Fredericks; P Galea; A W Moffett
Journal:  J Med Genet       Date:  1997-12       Impact factor: 6.318

4.  Unusual clinical history of a male infant with Edwards syndrome.

Authors:  Andrea Surányi; Tamás Bitó; György Vajda; László Kaiser; Gábor Gáspár; Márta Katona; János Szabó; Attila Pál
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.